RIVERSIDE UNIVERSITY HEALTH SYSTEM
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $364K
- Transactions
- 201
- Companies
- 23
- Average per transaction
- $1,809
Who reported the payments
| Novo Nordisk AS | $127,338 |
| Eli Lilly | $100,604 |
| Stryker | $33,830 |
| GE HealthCare | $27,933 |
| Johnson & Johnson | $18,467 |
| Acumed LLC | $11,428 |
| Gilead | $10,000 |
| Medline Industries LP | $7,458 |
| Acell, Inc. | $6,192 |
| AstraZeneca | $5,500 |
| C. R. Bard, Inc. & Subsidiaries | $3,579 |
| Abbott | $3,208 |
| Medical Device Business Services, Inc. | $2,000 |
| ICU Medical Inc | $1,554 |
| BD | $1,385 |
| KARL Storz Endoscopy-america | $1,245 |
| Bio-rad Laboratories, Inc. | $540 |
| Masimo Corporation | $480 |
| Siemens Medical Solutions USA, Inc. | $323 |
| Linvatec Corporation | $237 |
| Convatec Inc. | $156 |
| Hill-rom Company, Inc | $74 |
| CSL Behring | $28 |